Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia
Clinical trial NCT02390375 · COMPLETED
Trial details
- NCT number
- NCT02390375
- Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-04-01
- Enrollment
- 348
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.